The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
Open accessAbstract
To test the hypothesis that obesity/insulin resistance impairs both endothelium-dependent vasodilation and insulin-mediated augmentation of endothelium-dependent vasodilation, we studied leg blood flow (LBF) responses to graded intrafemoral artery infusions of methacholine chloride (MCh) or sodium nitroprusside (SNP) during saline infusion and euglycemic hyperinsulinemia in lean insulin-sensitive controls (C), in obese insulin-resistant subjects (OB), and in subjects with non-insulin-dependent diabetes mellitus (NIDDM). MCh induced increments in LBF were approximately 40% and 55% lower in OB and NIDDM, respectively, as compared with C (P < 0.05). Euglycemic hyperinsulinemia augmented the LBF response to MCh by - 50% in C (P < 0.05 vs saline) but not in OB and NIDDM. SNP caused comparable increments in LBF in all groups. Regression analysis revealed a significant inverse correlation between the maximal LBF change in response to MCh and body fat content. Thus, obesity/insulin resistance is associated with (a) blunted endothelium-dependent, but normal endothelium-independent vasodilation and (b) failure of euglycemic hyperinsulinemia to augment endothelium-dependent vasodilation. Therefore, obese/insulin-resistant subjects are characterized by endothelial dysfunction and endothelial resistance to insulin's effect on enhancement of endothelium-dependent vasodilation. This endothelial dysfunction could contribute to the increased risk of atherosclerosis in obese insulin-resistant subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, IR per se has a direct impact on endothelial function, distinct from effects related to unfavorable changes in lipid composition or blood pressure (9).”
From Improved Endothelial Function With Metformin in Type 2 Diabetes Mellitus (2001) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Kumar, M. V. J., & Chippada, A. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
Panza, J. A., Quyyumi, A. A., Brush, J. E., & Epstein, S. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230105 · Cited by 2,366
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
Vallance, P., Collier, J., & Moncada, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91013-1 · Cited by 1,590
Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N. S., & Baron, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,216
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11367.x · Cited by 1,158
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,117
Research works printed but not linked: 1
- Brozek, J., and A. Henschel. 1961. Techniques for measuring body com- position: proceedings of a conference. In Conference on Techniques for Mea- suring Body Composition. National Academy of Sciences, National Research Council. Washington DC. 78-89.
Cited by
Sorted by citations
Items 601–700 of 1,001
Wendelhag, I., Fagerberg, B., Hulthe, J., Bokemark, L., & Wikstrand, J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01036.x · Cited by 49
Mineralocorticoid receptors modulate vascular endothelial function in human obesity
Hwang, M.-H., Yoo, J.-K., Luttrell, M., Kim, H.-K., Meade, T. H., English, M., Segal, M. S., & Christou, D. D. (2013) · Clinical Science · doi:10.1042/cs20130200 · Cited by 48
Emerging Roles of SIRT3 in Cardiac Metabolism
Murugasamy, K., Munjal, A., & Sundaresan, N. R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.850340 · Cited by 48
“Obesity is characterized with elevated levels of fasting blood glucose and insulin, and is associated with insulin resistance and endothelial dysfunction (120, 121).”
BackgroundeNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity
Kashiwagi, S., Atochin, D. N., Li, Q., Schleicher, M., Pong, T., Sessa, W. C., & Huang, P. L. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.110 · Cited by 47
Hypoglycemic pharmacological treatment of type 2 diabetes: Targeting the endothelium
Nathanson, D., & Nyström, T. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.016 · Cited by 48
“Obesity and insulin resistance are independent risk factors for he development of endothelial dysfunction (Steinberg et al., 1996). nsulin is also an anti-lipolytic hormone and when the normal uppression of the release of free fatty acids (FFAs) from adipose issue is impaired by insulin resistance,…”
BackgroundPreserved endothelial function in human obesity in the absence of insulin resistance
Assar, M. E., de Adana, J. C. R., Angulo, J., Martínez, M. L. P., Matías, A. H., & Rodríguez‐Mañas, L. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-263 · Cited by 46
“In fact, an impairment of endothelial function associated to insulin resistance has been documented in different vascular districts [3,4,6,7].”
BackgroundHypertension in Postmenopausal Women
Leuzzi, C., & Modena, M. G. (2011) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/11588030-000000000-00000 · Cited by 48
High Inflammatory Activity Related to the Number of Metabolic Syndrome Components
Kırılmaz, B., Aşgün, H. F., Alioğlu, E., Ercan, E., Tengiz, İ., Türk, U. Ö., Saygı, S., & Özerkan, F. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00229.x · Cited by 48
Relationship of Metabolic Syndrome With Pulse Pressure in Patients With Essential Hypertension
Mulè, G., Nardi, E., Cottone, S., Cusimano, P., Incalcaterra, F., Palermo, A., Giandalia, M. E., Mezzatesta, G., Andronico, G., & Cerasola, G. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.07.016 · Cited by 48
de Chantemèle, E. J. B., Vessières, E., Guihot, A., Toutain, B., Maquignau, M., Loufrani, L., & Henrion, D. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn334 · Cited by 48
Cardiovascular Benefits of Exogenous Insulin
Chaudhuri, A., Dandona, P., & Fonseca, V. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1112 · Cited by 49
Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children
Tagi, V. M., Mainieri, F., & Chiarelli, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105814 · Cited by 48
“In fact, it contributes to an increase blood pressure (BP) in several ways, including the enhanced tissue angiotensin II (AngII) and aldosterone activities [2,3], the increased sympathetic nervous system activity [4], and oxidative stress [5].”
BackgroundSyamsunarno, M. R. A. A., Iso, T., Yamaguchi, A., Hanaoka, H., Putri, M., Obokata, M., Sunaga, H., Koitabashi, N., Matsui, H., Maeda, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090825 · Cited by 47
“The endothelium has emerged as a dynamic organ that regulates the systemic lipid metabolism and insulin sensitivity, and as such, endothelial dysfunction contributes to the pathogenesis of overnutrition-related metabolic disorders, such as type 2 diabetes and metabolic syndrome [1,2].”
BackgroundThiamine (Vitamin B1) Improves Endothelium-Dependent Vasodilatation in the Presence of Hyperglycemia
Arora, S., Lidor, A. O., Abularrage, C. J., Weiswasser, J. M., Nylén, E., Kellicut, D. C., & Sidawy, A. N. (2006) · Annals of Vascular Surgery · doi:10.1007/s10016-006-9055-6 · Cited by 46
Regulation of Muscle Blood Flow in Obesity
Hodnett, B. L., & Hester, R. L. (2007) · Microcirculation · doi:10.1080/10739680701282143 · Cited by 46
“These studies have shown impaired endothelium-dependent vasodilatory mechanisms in obese patients [54, 133, 140], with several studies suggesting that endothelial dysfunction occurs independently from overt diabetes [10, 55, 133].”
BackgroundBanerjee, D., Mayoral, A. R., Chitalia, N., & Kaski, J. C. (2011) · Clinical Cardiology · doi:10.1002/clc.20901 · Cited by 47
Diurnal Variation in Vascular and Metabolic Function in Diet-Induced Obesity
Prasai, M., Mughal, R. S., Wheatcroft, S. B., Kearney, M. T., Grant, P. J., & SCOTT, E. M. (2013) · Diabetes · doi:10.2337/db11-1740 · Cited by 47
“We and others have shown that obesity is associated with endothelial dysfunction in human (1,2) and animal studies (3).”
El‐Bassossy, H. M., Badawy, D., Neamatallah, T., & Fahmy, A. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.013 · Cited by 47
Lipid mediators in the regulation of endothelial barriers
Karki, P., & Birukov, K. G. (2017) · Tissue Barriers · doi:10.1080/21688370.2017.1385573 · Cited by 47
de Wilde, M. A., Eising, J. B., Gunning, M. N., Koster, M. P. H., Evelein, A. M. V., Dalmeijer, G. W., Uiterwaal, C. S. P. M., Eijkemans, M. J. C., van der Ent, C. K., Meijboom, F. J., et al. (2018) · Reproductive Sciences · doi:10.1177/1933719117749761 · Cited by 47
“Insulin resistance is associated with endothelial dysfunction, which may emerge already during childhood by accumulation of lipids within the blood vessel walls.(14,15) As a result, children from women with PCOS might also show signs of vascular changes early in life.”
BackgroundDDAH gene and cardiovascular risk
Valkonen, V.-P., Tuomainen, T., & Laaksonen, R. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm600oa · Cited by 47
Microvascular dysfunction in women with polycystic ovary syndrome
Lakhani, K., Leonard, A., Seifalian, A. M., & Hardiman, P. J. (2005) · Human Reproduction · doi:10.1093/humrep/dei199 · Cited by 47
Short-term weight loss reverses obesity-induced microvascular endothelial dysfunction
Csipo, T., Fulop, G. A., Lipecz, A., Tarantini, S., Kiss, T., Balasubramanian, P., Csiszar, A., Ungvari, Z., & Yabluchanskiy, A. (2018) · GeroScience · doi:10.1007/s11357-018-0028-9 · Cited by 50
“A critical mechanism by which obesity promotes vascular pathologies involves impairment of endothelial function (Steinberg et al. 1996).”
BackgroundYan, R. T., Yan, A. T.-K., Anderson, T. J., Buithieu, J., Charbonneau, F., Title, L. M., Verma, S., & Lonn, E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.053 · Cited by 45
Hinchee‐Rodriguez, K., Garg, N., Venkatakrishnan, P., Roman, M. G., Adamo, M. L., Masters, B. S. S., & Roman, L. J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.020 · Cited by 46
Contribution of insulin resistance to vascular dysfunction
Anfossi, G., Russo, I., Doronzo, G., & Trovati, M. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903136791 · Cited by 49
“Endothelial dysfunction is characterized by a reduced increase of blood flow in response to endothelium-dependent vasodilators, including insulin (McVeigh et al., 1992; Steinberg et al., 1996; Hogikyan et al., 1998), as well as an increase of circulating levels of specific markers of endothelial activation, such as vo…”
BackgroundToll-like receptor 2 mediates high-fat diet-induced impairment of vasodilator actions of insulin
Jang, H.-J., Kim, H.-S., Hwang, D. H., Quon, M. J., & Kim, J. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00578.2012 · Cited by 45
Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective
Romualdi, D., Costantini, B., Selvaggi, L., Giuliani, M., Cristello, F., Macrì, F., Bompiani, A., Lanzone, A., & Guido, M. (2008) · Human Reproduction · doi:10.1093/humrep/den230 · Cited by 45
Gremmels, H., Bevers, L. M., Fledderus, J. O., Braam, B. G., van Zonneveld, A. J., Verhaar, M. C., & Joles, J. A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.01.005 · Cited by 48
“Insulin has direct, eNOS-dependent, vasodilator effects on the endothelium (Steinberg et al., 1994), which are reduced in subjects with impaired glucose tolerance and diabetes (Steinberg et al., 1996).”
BackgroundKim, F., Tysseling, K. A., RICE, J., Gallis, B. M., Haji, L., Giachelli, C. M., Raines, E. W., Corson, M. A., & Schwartz, M. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.05.009 · Cited by 46
“Similarly, the ability of insulin to increase endothelium-dependent vasodilation in healthy human subjects [18] is diminished in individuals with insulin resistance, and insulin-mediated glucose disposal correlates inversely with the severity of endothelial dysfunction [19].”
BackgroundCardiovascular Risk Factors in Healthy Women with Previous Gestational Hypertension
Paradisi, G., Biaggi, A., Savone, R., Ianniello, F., Tomei, C., Caforio, L., & Caruso, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1337 · Cited by 46
Endothelial effects of antihypertensive treatment: focus on irbesartan
Negro, R. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.89 · Cited by 51
“In vitro studies have demonstrated that CRP, which is particularly elevated in diabetic patients, induces direct damage at the endothelial level leading to a reduction in NO and vasodilating prostaglandins and an increase in ET-1.”
InfluentialSaiki, R., Okazaki, M., Iwai, S., Kumai, T., Kobayashi, S., & Oguchi, K. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070619 · Cited by 46
Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance
Miller, A. W., Dimitropoulou, C., Han, G., White, R. E., Busija, D. W., & Carrier, G. O. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.4.h1524 · Cited by 46
“resistant human subjects (27) as well as animals (16, 21, 28) that demonstrated impaired endothelium-dependent relaxation.”
BackgroundPTEN Phosphorylation and Nuclear Export Mediate Free Fatty Acid-Induced Oxidative Stress
Wu, Y., Zhou, H., Wu, K., Lee, S., Li, R., & Liu, X. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5498 · Cited by 46
“Inappropriate elevation of plasma free fatty acids (FFA) has been reported in metabolic syndrome (23), and this impaired metabolism is associated with endothelial dysfunction (52) and cardiovascular diseases (57).”
SFAs do not impair endothelial function and arterial stiffness
Sanders, T. A. B., Lewis, F. J., Goff, L. M., & Chowienczyk, P. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.063644 · Cited by 47
“Insulin resistance has been shown to be associated with impaired endothelial function (5), and there is a close correlation between insulin sensitivity and basal insulin production in healthy subjects (6).”
BackgroundAutonomic Blockade Reverses Endothelial Dysfunction in Obesity-Associated Hypertension
Gamboa, A. C., Figueroa, R., Paranjape, S. Y., Farley, G., Diedrich, A., & Biaggioni, I. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07681 · Cited by 45
Schinzari, F., Tesauro, M., & Cardillo, C. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000469 · Cited by 46
Adipocyte-Endothelium Crosstalk in Obesity
Sabaratnam, R., & Svenningsen, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.681290 · Cited by 50
Update on the cardiometabolic syndrome
Sowers, J. R. (2001) · Clinical cornerstone · doi:10.1016/s1098-3597(01)90026-2 · Cited by 44
Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes
Lee, S. J., Lee, D. W., Kim, K. S., & Lee, I. K. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00339-4 · Cited by 45
Perségol, L., Vergès, B. L., Gambert, P., & Duvillard, L. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600309-jlr200 · Cited by 45
Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications
Tousoulis, D., Tsarpalis, K., Cokkinos, D. V., & Stefanadis, C. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00818.x · Cited by 45
Winkelmann, B. R., Boehm, B. O., Nauck, M., Kleist, P., März, W., Verho, N. K., Ranjith, N., & KNEISSL, G. D. (2001) · Current Medical Research and Opinion · doi:10.1185/030079901317010801 · Cited by 44
O’Brien, S. F., McKendrick, J. D., Radomski, M. W., Davidge, S. T., & Russell, J. C. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y97-186 · Cited by 45
Insulin Status and Vascular Responses to Weight Loss in Obesity
Bigornia, S., Farb, M. G., Tiwari, S., Karki, S., Hamburg, N. M., Vita, J. A., Hess, D. T., LaValley, M. P., Apovian, C. M., & Gokce, N. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.078 · Cited by 44
IMPACT OF OBESITY AND INSULIN RESISTANCE ON VASOMOTOR TONE: NITRIC OXIDE AND BEYOND
Stepp, D. W. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04381.x · Cited by 44
“In 1996, Steinberg et al.(27) demonstrated that endothelium-dependent vasodilation of the leg circulation was impaired in obese patients with metabolic dysfunction, but not in patients with only clinical hypertension or frank type II diabetes.”
BackgroundSanturé, M., Pǐtre, M., Marette, A., Deshaies, Y., Lemieux, C., Larivière, R., Nadeau, A., & Bachelard, H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704864 · Cited by 46
“…as previously British Journal of Pharmacology vol 137 (2) reported in muscle vascular bed of obese subjects and diabetic patients (McVeigh et al., 1992; Steinberg et al., 1994; 1996), and in arteries isolated from fructose-fed rats, and diabetic rats (Meraji et al., 1987; Verma et al., 1996).”
BackgroundRelationship between Metabolic Syndrome and Early Stage Coronary Atherosclerosis
Hitsumoto, T., Takahashi, M., Iizuka, T., & Shirai, K. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e506 · Cited by 43
The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes
Nogueira, A. I., Santos, R. A. S., Silva, A. C. S. E., Cabral, A. C. V., Vieira, R. L. P., Drumond, T. C., Machado, L. J. D. C., Freire, C. M. V., & Ribeiro‐Oliveira, A. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2006.12.014 · Cited by 44
“Considering that both gestational diabetes and endothelial dysfunction have been described as related to insulin resistance [28–30], it gives rise to a hypothesis that insulin resistance may be the link to these two conditions.”
BackgroundHepatocyte growth factor as a potential index of complication in diabetes mellitus
Nakamura, S., Morishita, R., Moriguchi, A., Yo, Y., Nakamura, Y., Hayashi, S.-I., Matsumoto, K., Matsumoto, K., Nakamura, T., Higaki, J., et al. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816121-00025 · Cited by 44
Sundell, J., Laine, H. K., Nuutila, P., Rönnemaa, T., Luotolahti, M., Raitakari, O. T., & Knuuti, J. M. (2002) · Diabetologia · doi:10.1007/s00125-002-0819-4 · Cited by 44
“However, in peripheral vasculature insulin, possibly by potentiating endothelium-dependent vasodilation, has been found to enhance the effect of endothelium-dependent vasodilators before any changes in basal blood flow can be detected [44, 45].”
Vascular function of the peripheral circulation in patients with nephrosis
Watts, G. F., Herrmann, S., Dogra, G. K., Playford, D. A., Best, J. D., Thomas, M., & Irish, A. B. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00785.x · Cited by 44
Altered neurovascular control of the resting circulation in human metabolic syndrome
Limberg, J. K., Morgan, B. J., Sebranek, J. J., Proctor, L. T., Walker, B. J., Eldridge, M. W., & Schrage, W. G. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.239780 · Cited by 43
“Consistent with this, research in humans supports the presence of endothelial dysfunction in MetSyn (Steinberg et al. 1996).”
ResultStatins in the Treatment of Polycystic Ovary Syndrome
Kodaman, P. H., & Dulęba, A. J. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-992933 · Cited by 43
Asymmetric dimethylarginine concentrations are elevated in women with gestational diabetes
Aktürk, M., Altınova, A. E., Mert, İ., Dinçel, A. S., Sargın, A., Büyükkağnıcı, Ü., Arslan, M., & Danışman, N. (2010) · Endocrine · doi:10.1007/s12020-010-9361-1 · Cited by 42
“and HOMA-IR, because the relationship between insulin resistance and NO has been observed [25].”
BackgroundBritton, K. A., Wang, N., Palmisano, J. N., Corsini, E. M., Schlett, C. L., Hoffmann, U., Larson, M. G., Vasan, R. S., Vita, J. A., Mitchell, G. F., et al. (2013) · Obesity · doi:10.1002/oby.20166 · Cited by 43
“2 (99 6 21) Postmenopausal, N (%) 644 (48) Hormone replacement therapy, N (%) 285 (21) Diabetes, N (%) 168 (6) Hypertension treatment, N (%) 481 (17) Lipid treatment, N (%) 358 (13) Prevalent cardiovascular disease, N (%) 117 (4) Adiposity measures BMI (kg/m(2)) 27.”
BackgroundNovel Therapies Targeting Vascular Endothelium
Tousoulis, D., Antoniades, C. A., Κούμαλλος, Ν., Marinou, K., Stefanadi, E., Latsios, G., & Stefanadis, C. (2006) · Endothelium · doi:10.1080/10623320601061714 · Cited by 42
Meta-inflammation and cardiometabolic disease in obesity: Can heat therapy help?
Ely, B. R., Clayton, Z. S., McCurdy, C. E., Pfeiffer, J. D., & Minson, C. T. (2017) · Temperature · doi:10.1080/23328940.2017.1384089 · Cited by 46
Chang, Y., Ho, C., Chu, C., Wang, J., Tseng, S.-H., & Jan, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201627 · Cited by 43
Salt-Sensitivity of Blood Pressure and Insulin Resistance
Ertuğlu, L. A., Elijovich, F., Laffer, C. L., & Kirabo, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.793924 · Cited by 44
Oxidative Stress, Vascular Endothelium, and the Pathology of Neurodegeneration in Retina
Shi, X., Li, P., Liu, H., & Prokosch, V. (2022) · Antioxidants · doi:10.3390/antiox11030543 · Cited by 47
Lee, J., Shirodaria, C. C., Jackson, C., Robson, M. D., Antoniades, C. A., Francis, J. M., Wiesmann, F., Channon, K. M., Neubauer, S., & Choudhury, R. P. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.005 · Cited by 43
Naderali, E. K. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00367-2 · Cited by 43
Skilton, M. R., Sieveking, D. P., Harmer, J. A., Franklin, J., Loughnan, G., Nakhla, S., SULLIVAN, D. R., Caterson, I. D., & Celermajer, D. S. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00817.x · Cited by 44
Profilin acts downstream of LDL to mediate diabetic endothelial cell dysfunction
Romeo, G. R., Frangioni, J. V., & Kazlauskas, A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0841fje · Cited by 43
Onat, A., Hergenç, G., Sarı, İ., Türkmen, S., Can, G., & Sansoy, V. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.10.017 · Cited by 43
Matsumoto, K., Miyake, S., Yano, M., Ueki, Y., & Tominaga, Y. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00487-6 · Cited by 43
Piatti, P., Monti, L. D., Zavaroni, I., Valsecchi, G., Phan, C. V., Costa, S., Conti, M., Sandoli, E. P., Solerte, B., Pozza, G., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6667 · Cited by 43
Waeber, B., Feihl, F., & Ruilope, L. M. (2001) · Blood Pressure · doi:10.1080/080370501753400610 · Cited by 45
“As already pointed out endothelial dysfunction may be seen before the development of type 2 diabetes [21].”
BackgroundResultAntidiabetic and hypolipidemic potential of DRF 2519—a dual activator of PPAR-α and PPAR-γ
Chakrabarti, R., Misra, P., Vikramadithyan, R. K., Mamnoor, P., Hiriyan, J., Datla, S. R., Damarla, R. K. B., Suresh, J., & Rajagopalan, R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.03.034 · Cited by 43
Insulin action in muscle and adipose tissue in type 2 diabetes: The significance of blood flow
Lambadiari, V., Τriantafyllou, Κ., & Dimitriadis, G. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.626 · Cited by 42
WNT5A-JNK regulation of vascular insulin resistance in human obesity
Farb, M. G., Karki, S., Park, S., Saggese, S. M., Carmine, B. J., Hess, D. T., Apovian, C. M., Fetterman, J. L., Bretón‐Romero, R., Hamburg, N. M., et al. (2016) · Vascular Medicine · doi:10.1177/1358863x16666693 · Cited by 42
Stolberg, C. R., Mundbjerg, L. H., Funch-Jensen, P. M., Gram, B., Bladbjerg, E., & Juhl, C. B. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.04.002 · Cited by 42
Jo, E., Cho, K. I., Park, J.-J., Im, D.-S., Choi, J.-H., & Kim, B.-J. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0128 · Cited by 43
Coronary Circulatory Function Abnormalities in Insulin Resistance
Schelbert, H. R. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.053 · Cited by 42
“Indeed, the presence of functional, mostly ndothelium-related, alterations of the peripheral circulaion has been demonstrated in persons with mild, preiabetic IR (4,5).”
BackgroundRenal functional reserve in obesity hypertension
Pecly, I. M. D., Genelhu, V. A., & Francischetti, E. A. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01037.x · Cited by 42
Endothelial Function Varies According to Insulin Resistance Disease Type
Beckman, J. A., Goldfine, A. B., Dunaif, A. E., Gerhard‐Herman, M. D., & Creager, M. A. (2007) · Diabetes Care · doi:10.2337/dc06-2142 · Cited by 42
Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia
Jonkers, I. J. A. M., de Man, F. H. A. F., van der Laarse, A., Frölich, M., Leuven, J. A. G., Kamper, A. M., Blauw, G. J., & Smelt, A. H. M. (2001) · Journal of Hypertension · doi:10.1097/00004872-200104000-00012 · Cited by 42
Free fatty acids normalize a rosiglitazone-induced visfatin release
Haider, D. G., Mittermayer, F., Schaller, G., Artwohl, M., Baumgartner-Parzer, S. M., Prager, G., Roden, M., & Wolzt, M. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00109.2006 · Cited by 39
McCarty, M. F. (2000) · Medical Hypotheses · doi:10.1054/mehy.2000.1075 · Cited by 43
Vehkavaara, S., Westerbacka, J., Hakala‐Ala‐Pietilä, T., Virkamäki, A., Hovatta, O., & Yki‐Järvinen, H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7034 · Cited by 43
“Given that both insulin (7, 73 ) and estradiol (74 ‐77) vasodilate via an endothelium-dependent mechanism, it seemed reasonable to hypothesize that estradiol and insulin have additive or even synergistic effects on peripheral blood flow.”
BackgroundIdentification of a new secretory factor, CCDC3/Favine, in adipocytes and endothelial cells
Kobayashi, S., Fukuhara, A., Taguchi, T., Matsuda, M., Tochino, Y., Otsuki, M., & Shimomura, I. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.142 · Cited by 41
Han, K., Patel, Y. R., Lteif, A. A., Chisholm, R., & Mather, K. J. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1183 · Cited by 41
Medina, J. S., Muñoz, M., Rodríguez, C., Sánchez, A., Contreras, C., Carballido, J., & Prieto, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020912 · Cited by 46
“Overweight and obesity-associated ED was first reported in clinical studies demonstrating blunted increases in leg blood flow in response to the administration of endotheliumdependent agonists in obese patients with an augmented body mass index (BMI) [33].”
BackgroundEndothelial dysfunction and hypertension in diabetes mellitus
Dandona, P., Chaudhuri, A., & Aljada, A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.006 · Cited by 40
Martin, D. J., Haq, Z. U., Nicholl, B. I., Cullen, B., Evans, J. J., Gill, J. M. R., Roberts, B. A., Gallacher, J., Mackay, D., McIntosh, A. M., et al. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.157784 · Cited by 42
“…and cardiometabolic disease, including (but not limited to) abnormalities of the hypothalamic–pituitary–adrenal (HPA) axis, 39–42 oxidative stress processes, 43 shared genetic vulnerability, 44–47 abnormal inflammatory responses, 48,49 endothelial dysfunction 50,51 and haemodynamic reactivity.”
Impairment of endothelial function after a high-fat meal in patients with coronary artery disease
Zhao, S., Liu, L., Gao, M., Zhou, Q., Li, Y.-L., & Xia, B. (2001) · Coronary Artery Disease · doi:10.1097/00019501-200111000-00006 · Cited by 41
Naderali, E. K., Smith, S. L., DOYLE, P. J., & Williams, G. (2000) · Clinical Science · doi:10.1042/cs1000055 · Cited by 46
Dagres, N., Saller, B., Haude, M., Hüsing, J., von Birgelen, C., Schmermund, A., Sack, S., Baumgart, D., Mann, K., & Erbel, R. M. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02156.x · Cited by 41
“Indeed, studies in individuals with insulin-resistant states such as obesity or type 2 diabetes indicate blunted insulin-mediated vasodilation (Laakso et al., 1992; Steinberg et al., 1996; Williams et al., 1996).”
BackgroundGerber, R. T., Holemans, K., O'Brien-Coker, I., Mallet, A. I., van Bree, R., Assche, F. A. V., & Poston, L. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0607t.x · Cited by 40
“Affected patients (Steinberg et al. 1996), including those with non_insulin dependent diabetes (McVeigh et al. 1992), demonstrate blunted endothelium-dependent vasodilatation.”
BackgroundSundell, J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00375.x · Cited by 41
Laight, D. W., Desai, K. M., Änggård, E., & CARRIER, M. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00451-9 · Cited by 41
Love, K. M., Liu, J., Regensteiner, J. G., Reusch, J. E. B., & Liu, Z. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13045 · Cited by 40
Cederholm, J., & Zethelius, B. (2019) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2019.1680583 · Cited by 42
“The finding here, of several insulin resistance indexes to be strong predictors of CVD risk independently of several important conventional cardiovascular risk factors and comorbidities, underlines that insulin resistance also may be associated with other risk factors like endothelial dysfunction (39), chronic subclin…”
BackgroundVascular endothelial insulin/IGF-1 signaling controls skin wound vascularization.
Aghdam, S. Y., Eming, S., Willenborg, S., Neuhaus, B., Niessen, C., Partridge, L., Krieg, T., & Brüning, J. (2012) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2012.03.134 · Cited by 43
Ramirez, C. E., Shuey, M. M., Milne, G. L., Gilbert, K., Nian, H., Yu, C., Luther, J. M., & Brown, N. J. (2014) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2014.08.001 · Cited by 40
“Insulin sensitivity reflects both the perfusion of insulin-sensitive tissues[22,23] and insulin signaling in those tissues.”
BackgroundLimberg, J. K., Harrell, J. W., Johansson, R., Eldridge, M. W., Proctor, L. T., Sebranek, J. J., & Schrage, W. G. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00291.2013 · Cited by 40
The Effect of Moxonidine on Endothelial Dysfunction in Metabolic Syndrome
Topal, E., Çıkım, A. S., Çıkım, K., Temel, İ., & Оздемир, Р. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606050-00007 · Cited by 40
The vascular endothelium in diabetes—a therapeutic target?
Mather, K. J. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9237-9 · Cited by 41
“In cross-sectional studies there is an association between elevated fatty acid concentrations and vascular dysfunction [60, 61].”
Metadata
- Authors
- Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D.
- Affiliations
- Indiana University (US)
- Richard L. Roudebush VA Medical Center (US)
- Indiana University Hospital (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-06-01
- Volume
- 97
- Issue
- 11
- Pages
- 2601-2610
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507347
- OpenAlex
- W1982811953
- Cited by
- 1,687
- References
- 59
- Citations by year
- 2026: 11 · 2025: 23 · 2024: 17 · 2023: 30 · 2022: 19 · 2021: 32 · 2020: 30 · 2019: 36 · 2018: 36 · 2017: 46 · 2016: 50 · 2015: 51 · 2014: 69 · 2013: 69 · 2012: 61
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- American Heart Association
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK42469, P60DK020542, DK20542)
- National Center for Research Resources (M 01-RR750-19)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- obesity, insulin resistance, endothelial dysfunction, endothelium-dependent vasodilation, euglycemic hyperinsulinemia, leg blood flow, methacholine, sodium nitroprusside, type 2 diabetes, fat mass, atherosclerosis risk
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Cholesterol, Diabetes Mellitus, Type 2, Endothelium, Vascular, Fatty Acids, Nonesterified, Glucose, Humans, Hyperinsulinism, Infusions, Intra-Arterial, Infusions, Intravenous, Insulin, Insulin Resistance, Leg, Cholesterol, HDL, Cholesterol, LDL, Nitroprusside, Obesity, Reference Values, Regional Blood Flow, Syndrome, Time Factors, Triglycerides, Vasodilation, Glucose Clamp Technique, Body Mass Index, Methacholine Chloride
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review